ALTHX: THX Pharma Société Anonyme - Summary | Jitta

THX Pharma Société Anonyme

FRA:ALTHX

Price
€3.38
Loss Chance
58.4%
0.45JITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
486 / 502
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (27)
Recent Business Performance (33)
Financial Strength (23)
Return to Shareholders (13)
Competitive Advantage (27)
Jitta Signs
Recent Business PerformanceEarning Growth Last Year
SG&A to SalesDecreasing
Cash Conversion CycleLess than 30 days
Revenue and EarningEarning loss detected in 2024
Operating MarginInconsistent
New Share IssuedMore than 50% in 5 years
CapExVery High
Key Stats
Jitta Score
Jitta Line
0.45
100.00%
4.50
90.73%
2.82
128.55%
Pharmaceuticals
3.28
100.00%
3.52
100.00%
4.96
66.02%
COMPANY DESCRIPTION
THX Pharma Société Anonyme, a biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system disorders. It is involved in the development of Batten-1, an initial drug candidate currently under Phase ½ clinical study for Batten disease. The company was formerly known as Theranexus Société Anonyme and change its name to THX Pharma Société Anonyme in September 2025. The company was founded in 2013 and is headquartered in Lyon, France.